Acute Promyelocytic Leukemia and Brugada Syndrome: A Report on the Safety of Arsenic Trioxide/All-Trans-Retinoic Acid Therapy

Acute promyelocytic leukemia (APL) is a rare and aggressive form of acute myeloid leukemia (AML). Instead of cytotoxic chemotherapy, a combination of all-trans-retinoic acid (ATRA) and arsenic trioxide (ATO) represents front-line therapy in low-risk patients. However, the therapeutic approach could...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosati, Giorgio, Camerlo, Sofia, Dalmazzo, Matteo, Padrini, Melissa, Busana, Tiziano Tommaso, De Gobbi, Marco, Fornari, Alessandro, Morotti, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366891/
https://www.ncbi.nlm.nih.gov/pubmed/37489375
http://dx.doi.org/10.3390/hematolrep15030045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366891/
https://www.ncbi.nlm.nih.gov/pubmed/37489375
http://dx.doi.org/10.3390/hematolrep15030045

Ejemplares similares